MANA Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,108
Closed -$291K 115
2020
Q2
$291K Buy
+1,108
New +$296K 1.25% 31
2019
Q4
Sell
-1,189
Closed -$285K 124
2019
Q3
$285K Buy
+1,189
New +$326K 1.21% 36
2019
Q2
Sell
-1,083
Closed -$311K 179
2019
Q1
$311K Sell
1,083
-300
-22% -$86.8K 1.01% 32
2018
Q4
$363K Buy
+1,383
New +$380K 2.33% 8
2018
Q2
Sell
-1,428
Closed -$314K 114
2018
Q1
$314K Buy
+1,428
New +$335K 0.46% 100

Other funds holding ELV

MANA Advisors's ELV Position: Q3 2020 in Review

MANA Advisors sold out of Elevance Health (ELV) in Q3 2020, closing a stake of 1,108 shares — an estimated $291K sold.

MANA Advisors first reported a position in ELV in Q1 2018 and held it in 5 quarters. The position peaked at $363K in Q4 2018. 1,095 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • MANA Advisors reported no remaining Elevance Health position as of Q3 2020 after selling out during the quarter.
  • MANA Advisors sold 1,108 Elevance Health shares in Q3 2020, an estimated $291K.
  • MANA Advisors first reported a position in Elevance Health in Q1 2018 and held it in 5 quarters.
  • MANA Advisors's Elevance Health position peaked at $363K in Q4 2018.
  • 1,095 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on MANA Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.